β-amyloid controls altered Reelin expression and processing in Alzheimer's disease

Neurobiology of Disease

Volumn 37, Issue 3, 2010, Pages 682-691

  Botella López, Arancha ^a,b   Cuchillo Ibáñez, Inmaculada ^a,b   Cotrufo, Tiziana ^b,c   Mok, Su San ^d,e   Li, Qiao Xin ^d,e   Barquero, María Sagrario ^f   Dierssen, Mara ^g   Soriano, Eduardo ^b,c   Sáez Valero, Javier ^a,b  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^f HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^g UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

Alzheimer's disease; Amyloid; Cerebral cortex; Down's syndrome; Glycoprotein; Reelin

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; GLYCOPROTEIN; MESSENGER RNA; REELIN;

ADULT; AGED; ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; CHROMOSOME 21; CONTROLLED STUDY; DOWN SYNDROME; FETUS; FRONTAL CORTEX; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; MEMORY CONSOLIDATION; MOUSE; NERVE CELL PLASTICITY; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE;

ADULT; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BRAIN; CELL ADHESION MOLECULES, NEURONAL; CELL LINE, TUMOR; CHROMOSOMES, HUMAN, PAIR 21; DOWN SYNDROME; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FETUS; GENE EXPRESSION REGULATION; GLYCOSYLATION; HUMANS; MALE; MICE; MIDDLE AGED; NERVE TISSUE PROTEINS; NEURONAL PLASTICITY; RNA, MESSENGER; SENILE PLAQUES; SERINE ENDOPEPTIDASES; SYNAPSES; UP-REGULATION;

EID: 76149127988     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2009.12.006     Document Type: Article

References (66)

1. Alcántara S., Ruiz M., D'Arcangelo G., Ezan F., de Lecea L., Curran T., Sotelo C., and Soriano E. Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse. J. Neurosci. 18 (1998) 7779-7799
2. American Psychiatric Association, 2000. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. American Psychiatric Association, Washington, DC.
3. Bar I., and Goffinet A.M. Developmental neurobiology. Decoding the Reelin signal. Nature 399 (1999) 645-646
4. Beffert U., Morfini G., Bock H.H., Reyna H., Brady S.T., and Herz J. Reelin-mediated signalling locally regulates protein kinase B/Akt and glycogen synthase kinase 3beta. J. Biol. Chem. 77 (2002) 49958-49964
5. Beffert U., Weeber E.J., Durudas A., Qiu S., Masiulis I., Sweatt J.D., Li W.P., Adelmann G., Frotscher M., Hammer R.E., and Herz J. Modulation of synaptic plasticity and memory by Reelin involves differential splicing of the lipoprotein receptor Apoer2. Neuron 47 (2005) 567-579
6. Beffert U., Durudas A., Weeber E.J., Stolt P.C., Giehl K.M., Sweatt J.D., Hammer R.E., and Herz J. Functional dissection of Reelin signaling by site-directed disruption of Disabled-1 adaptor binding to apolipoprotein E receptor 2: distinct roles in development and synaptic plasticity. J. Neurosci. 26 (2006) 2041-2052
7. Biroccio A., Del Boccio P., Panella M., Bernardini S., Di Ilio C., Gambi D., Stanzione P., Sacchetta P., Bernardi G., Martorana A., Federici G., Stefani A., and Urbani A. Differential post-translational modifications of transthyretin in Alzheimer's disease: a study of the cerebral spinal fluid. Proteomics 6 (2006) 2305-2313
8. Borroni B., Malinverno M., Gardoni F., Alberici A., Parnetti L., Premi E., Bonuccelli U., Grassi M., Perani D., Calabresi P., Di Luca M., and Padovani A. Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy. Neurology 71 (2008) 1796-1803
9. Botella-López A., and Sáez-Valero J. Alzheimer's and Reelin. In: Fatemi R.H. (Ed). Reelin glycoprotein, biology, structure and roles in health and disease (2008), Springer, New York 401-409
10. Botella-López A., Burgaya F., Gavín R., García-Ayllon M.S., Gómez-Tortosa E., Peña-Casanova J., Ureña J.M., Del Río J.A., Blesa R., Soriano E., and Sáez-Valero J. Reelin expression and glycosylation patterns are altered in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 5573-5578
11. Buerger K., Otto M., Teipel S.J., Zinkowski R., Blennow K., DeBernardis J., Kerkman D., Schröder J., Schönknecht P., Cepek L., McCulloch C., Möller H.J., Wiltfang J., Kretzschmar H., and Hampel H. Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease. Neurobiol. Aging 27 (2006) 10-15
12. Chin J., Massaro C.M., Palop J.J., Thwin M.T., Yu G.Q., Bien-Ly N., Bender A., and Mucke L. Reelin depletion in the entorhinal cortex of human amyloid precursor protein transgenic mice and humans with Alzheimer's disease. J. Neurosci. 27 (2007) 2727-2733
13. Cooper J.A., and Howell B.W. Lipoprotein receptors: signaling functions in the brain?. Cell 97 (1999) 671-674
14. D'Arcangelo G., Homayouni R., Keshvara L., Rice D.S., Sheldon M., and Curran T. Reelin is a ligand for lipoprotein receptors. Neuron 24 (1999) 471-479
15. de Bergeyck V., Naerhuyzen B., Goffinet A.M., and Lambert de Rouvroit C. A panel of monoclonal antibodies against reelin, the extracellular matrix protein defective in reeler mutant mice. J. Neurosci. Methods 82 (1998) 17-24
16. Deguchi K., Inoue K., Avila W.E., Lopez-Terrada D., Antalffy B.A., Quattrocchi C.C., Sheldon M., Mikoshiba K., D'Arcangelo G., and Armstrong D.L. Reelin and disabled-1 expression in developing and mature human cortical neurons. J. Neuropathol. Exp. Neurol. 62 (2003) 676-684
17. Encinas M., Iglesias M., Liu Y., Wang H., Muhaisen A., Ceña V., Gallego C., and Comella J.X. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J. Neurochem. 75 (2000) 991-1003
18. Fodero L.R., Sáez-Valero J., Barquero M.S., Marcos A., McLean C.A., and Small D.H. Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid. J. Neurochem. 79 (2001) 1022-1026
19. George A.J., Holsinger R.M., McLean C.A., Laughton K.M., Beyreuther K., Evin G., Masters C.L., and Li Q.X. APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease. Neurobiol. Dis. 16 (2004) 124-132
20. George A.J., Holsinger R.M., McLean C.A., Tan S.S., Scott H.S., Cardamone T., Cappai R., Masters C.L., and Li Q.X. Decreased phosphatidylethanolamine binding protein expression correlates with Abeta accumulation in the Tg2576 mouse model of Alzheimer's disease. Neurobiol. Aging 27 (2006) 614-623
21. Glenner G.G., and Wong C.W. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122 (1984) 1131-1135
22. Groc L., Choquet D., Stephenson F.A., Verrier D., Manzoni O.J., and Chavis P. NMDA receptor surface trafficking and synaptic subunit composition are developmentally regulated by the extracellular matrix protein Reelin. J. Neurosci. 27 (2007) 10165-10175
23. Grundke-Iqbal I., Iqbal K., Tung Y.C., Quinlan M., Wisniewski H.M., and Binder L.I. Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc. Natl. Acad. Sci. USA 83 (1986) 4913-4917
24. Guevara J., Espinosa B., Zenteno E., Vázguez L., Luna J., Perry G., and Mena R. Altered glycosylation pattern of proteins in Alzheimer disease. J. Neuropathol. Exp. Neurol. 57 (1998) 905-914
25. Herz J., and Chen Y. Reelin, lipoprotein receptors and synaptic plasticity. Nat. Rev. Neurosci. 7 (2006) 850-859
26. Hiesberger T., Trommsdorff M., Howell B.W., Goffinet A., Mumby M.C., Cooper J.A., and Herz J. Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24 (1999) 481-489
27. Hoareau C., Borrell V., Soriano E., Krebs M.O., Prochiantz A., and Allinquant B. Amyloid precursor protein cytoplasmic domain antagonizes reelin neurite outgrowth inhibition of hippocampal neurons. Neurobiol. Aging 29 (2008) 542-553
28. Hoe H.S., Tran T.S., Matsuoka Y., Howell B.W., and Rebeck G.W. DAB1 and Reelin effects on amyloid precursor protein and ApoE receptor 2 trafficking and processing. J. Biol. Chem. 281 (2006) 35176-35185
29. Hoe H.S., Lee K.J., Carney R.S.E., Lee J., Markova A., Lee J.Y., Howell B.W., Hyman B.T., Pak D.T.S., Bu G., and Rebeck G.W. Interaction of Reelin with Amyloid Precursor Protein Promotes Neurite Outgrowth. J. Neurosci. 29 (2009) 7459-7473
30. Holm S. A simple sequentially rejective multiple test procedure. Scand. J. Statist. 6 (1979) 65-70
31. Howell B.W., Lanier L.M., Frank R., Gertler F.B., and Cooper J.A. The disabled 1 phosphotyrosine-binding domain binds to the internalization signals of transmembrane glycoproteins and to phospholipids. Mol. Cell. Biol. 19 (1999) 5179-5188
32. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., and Cole G. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274 (1996) 99-102
33. Irizarry M.C., McNamara M., Fedorchak K., Hsiao K., and Hyman B.T. APPSw transgenic mice develop age-related A beta deposits and neuropil abnormalities, but no neuronal loss in CA1. J. Neuropathol. Exp. Neurol. 56 (1997) 965-973
34. Kanai M., Matsubara E., Isoe K., Urakami K., Nakashima K., Arai H., Sasaki H., Abe K., Iwatsubo T., Kosaka T., Watanabe M., Tomidokoro Y., Shizuka M., Mizushima K., Nakamura T., Igeta Y., Ikeda Y., Amari M., Kawarabayashi T., Ishiguro K., Harigaya Y., Wakabayashi K., Okamoto K., Hirai S., and Shoji M. Longitudinal study of cerebrospinal fluid levels of tau, A beta1-40, and A beta1-42(43) in Alzheimer's disease: a study in Japan. Ann. Neurol. 44 (1998) 17-26
35. Kanninen K., Goldsteins G., Auriola S., Alafuzoff I., and Koistinaho J. Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach. Neurosci. Lett. 367 (2004) 235-240
36. Kawarabayashi T., Younkin L.H., Saido T.C., Shoji M., Ashe K.H., and Younkin S.G. Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease. J. Neurosci. 21 (2001) 372-381
37. Knuesel I., Nyffeler M., Mormède C., Muhia M., Meyer U., Pietropaolo S., Yee B.K., Pryce C.R., Laferla F.M., Marighetto A., and Feldon J. Age-related accumulation of Reelin in amyloid-like deposits. Neurobiol. Aging 30 (2009) 697-716
38. Kohno S., Kohno T., Nakano Y., Suzuki K., Ishii M., Tagami H., Baba A., and Hattori M. Mechanism and significance of specific proteolytic cleavage of Reelin. Biochem. Biophys. Res. Commun. 380 (2009) 93-97
39. Kornfeld K., Reitman M.L., and Kornfeld R. The carbohydrate-binding specificity of pea and lentil lectins. Fucose is an important determinant. J. Biol. Chem. 256 (1981) 6633-6640
40. Levenson J.M., Qiu S., and Weeber E.J. The role of reelin in adult synaptic function and the genetic and epigenetic regulation of the reelin gene. Biochim. Biophys. Acta 1779 (2008) 422-431
41. Lugli G., Krueger J.M., Davis J.M., Persico A.M., Keller F., and Smalheiser N.R. Methodological factors influencing measurement and processing of plasma reelin in humans. BMC Biochem. 4 (2003) 9
42. Mann D.M., Yates P.O., and Marcyniuk B. Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes. Neuropathol. Appl. Neurobiol. 10 (1984) 185-207
43. Manthorpe M., Fagnani R., Skaper S.D., and Varon S. An automated colorimetric microassay for neuronotrophic factors. Brain Res. 390 (1986) 191-198
44. Martínez-Cerdeño V., and Clascá F. Reelin immunoreactivity in the adult neocortex: a comparative study in rodents, carnivores, and non-human primates. Brain Res. Bull. 57 (2002) 485-488
45. Martínez-Cerdeño V., Galazo M.J., Cavada C., and Clasca F. Reelin immunoreactivity in the adult primate brain: intracellular localization in projecting and local circuit neurons of the cerebral cortex, hippocampus and subcortical regions. Cereb. Cortex 12 (2002) 1298-1311
46. Masters C.L., Simms G., Weinman N.A., Multhaup G., McDonald B.L., and Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 4245-4249
47. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
48. Miettinen R., Riedel A., Kalesnykas G., Kettunen H.P., Puoliväli J., Soininen H., and Arendt T. Reelin-immunoreactivity in the hippocampal formation of 9-month-old wildtype mouse: effects of APP/PS1 genotype and ovariectomy. J. Chem. Neuroanat. 30 (2005) 105-118
49. Motoi Y., Itaya M., Mori H., Mizuno Y., Iwasaki T., Hattori H., Haga S., and Ikeda K. Apolipoprotein E receptor 2 is involved in neuritic plaque formation in APP sw mice. Neurosci. Lett. 368 (2004) 144-147
50. Parisiadou L., and Efthimiopoulos S. Expression of mDab1 promotes the stability and processing of amyloid precursor protein and this effect is counteracted by X11alpha. Neurobiol. Aging 28 (2007) 377-388
51. Popov M., Li J., and Reithmeier R.A. Resolution of glycoproteins by a lectin gel-shift assay. Anal. Biochem. 279 (2000) 90-95
52. Rice D.S., and Curran T. Role of the reelin signaling pathway in central nervous system development. Annu. Rev. Neurosci. 24 (2001) 1005-1039
53. Roberts R.C., Xu L., Roche J.K., and Kirkpatrick B. Ultrastructural localization of reelin in the cortex in post-mortem human brain. J. Comp. Neurol. 482 (2005) 294-308
54. Sáez-Valero J., Sberna G., McLean C.A., Masters C.L., and Small D.H. Glycosylation of acetylcholinesterase as diagnostic marker for Alzheimer's disease. Lancet 350 (1997) 929
55. Sáez-Valero J., Sberna G., McLean C.A., and Small D.H. Molecular isoform distribution and glycosylation of acetylcholinesterase are altered in brain and cerebrospinal fluid of patients with Alzheimer's disease. J. Neurochem. 72 (1999) 1600-1608
56. Sáez-Valero J., Costell M., Sjogren M., Andreasen N., Blennow K., and Luque J.M. Altered levels of cerebrospinal fluid reelin in frontotemporal dementia and Alzheimer's disease. J. Neurosci. Res. 72 (2003) 132-136
57. Seripa D., Matera M.G., Franceschi M., Daniele A., Bizzarro A., Rinaldi M., Panza F., Fazio V.M., Gravina C., D'Onofrio G., Solfrizzi V., Masullo C., and Pilotto A. The RELN locus in Alzheimer's disease. J. Alzheimers Dis. 14 (2008) 335-344
58. Sihlbom C., Davidsson P., Sjögren M., Wahlund L.O., and Nilsson C.L. Structural and quantitative comparison of cerebrospinal fluid glycoproteins in Alzheimer's disease patients and healthy individuals. Neurochem. Res. 33 (2008) 1332-1340
59. Smalheiser N.R., Costa E., Guidotti A., Impagnatiello F., Auta J., Lacor P., Kriho V., and Pappas G.D. Expression of reelin in adult mammalian blood, liver, pituitary pars intermedia, and adrenal chromaffin cells. Proc. Natl. Acad. Sci. U. S. A. 97 (2000) 1281-1286
60. Schupf N., Tang M.X., Fukuyama H., Manly J., Andrews H., Mehta P., Ravetch J., and Mayeux R. Peripheral Abeta subspecies as risk biomarkers of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 14052-14057
61. Tissir F., and Goffinet A.M. Reelin and brain development. Nat. Rev. Neurosci. 4 (2003) 496-505
62. Trommsdorff M., Borg J.P., Margolis B., and Herz J. Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J. Biol. Chem. 273 (1998) 33556-33560
63. Trommsdorff M., Gotthardt M., Hiesberger T., Shelton J., Stockinger W., Nimpf J., Hammer R.E., Richardson J.A., and Herz J. Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97 (1999) 689-701
64. Weeber E.J., Beffert U., Jones C., Christian J.M., Forster E., Sweatt J.D., and Herz J. Reelin and ApoE receptors cooperate to enhance hippocampal synaptic plasticity and learning. J. Biol. Chem. 277 (2002) 39944-39952
65. Wirths O., Multhaup G., Czech C., Blanchard V., Tremp G., Pradier L., Beyreuther K., and Bayer T.A. Reelin in plaques of beta-amyloid precursor protein and presenilin-1 double-transgenic mice. Neurosci. Lett. 316 (2001) 145-148
66. Wisniewski K.E., Wisniewski H.M., and Wen G.Y. Occurrence of neuropathological changes and dementia of Alzheimer's disease in Down's syndrome. Ann. Neurol. 17 (1985) 278-282